Recent Funding Roundup: Guancheng Secures 50M RMB Series A, Xuanyu Raises Nearly 100M RMB – Who Will Lead the Medical Device Industry?

Aug 28, 2024 17:32 CST Updated 17:32

ShineyoMedical

Provider of Atrial Fibrillation Electrophysiology and Peripheral Vascular Intervention Solutions

Humatrix

Developer of Tissue Engineering and Regenerative Medicine Technologies

PULSECARE

Minimally Invasive Treatment Product Developer

Ansukang Medical

Innovative Device Developer

In the medical field, technological innovation and capital power have always been the twin engines driving industry development. Recently, several medical companies have successfully completed financing, injecting new vitality into the industry. Among them, Guancheng Information Technology (Suzhou) Co., Ltd. has drawn particular attention.

Guancheng Information

Completed Over 50 Million Pre-A and A Rounds of Financing, Accelerating the Digital and Intelligent Transformation of the Medical Device Industry

Recently, Guancheng Information Technology (Suzhou) Co., Ltd. (hereinafter referred to as "Guancheng Information"), an industrial software provider, has successfully completed its Pre-A and A rounds of financing, with a total amount exceeding 50 million yuan, jointly invested by SND Finance, Mr. Zhu Guodong, and Leading Future. The funds from this round will mainly be used for the continuous innovation and iteration of products, enriching product lines, and market expansion, further strengthening Guancheng Information's leading position in the digitalization field of the medical device industry.

In addition to Guancheng Information Technology (Suzhou) Co., Ltd., the following companies have also announced the completion of financing, jointly promoting the development of the medical industry:

ShineyoMedical

Completed Nearly 100 Million Yuan in Series A+ Financing, Accelerating the Launch of Cardiac Electrophysiology and Peripheral Vascular Intervention Products

ShineyoMedical, a provider focused on cardiac electrophysiology and peripheral vascular interventional treatment solutions, recently announced the completion of a nearly 100-million-yuan A+ round of financing. This round was led by Guangzhou Golden Control Fund, with participation from multiple investment institutions such as Zhuo Pu Capital, Jin Xin Capital, and Zhangjiagang Industrial Capital. Existing shareholder Xingzheng Capital continued its support.

Humstrix

Completed Series A Financing and Initiated Clinical Trials for Small-Caliber Artificial Blood Vessels Produced in China

Humatrix Medical (Suzhou) Co., Ltd. (Humatrix Medical, hereinafter referred to as "Humatrix Medical") announced the completion of its Series A financing. This round of financing was led by IDG Capital, with follow-up investments from existing shareholders Shanghai Biomedical Innovation and Transformation Fund and Huafang Capital. Wincome Capital served as the exclusive financial advisor.

Shijie Medical Technology (Guangzhou) Co., Ltd.

ShineyoMedical Announces Completion of Tens of Millions in Series A+ Financing; Radial Artery Neurointervention Enters Fast Track of Development

Shijie Medical Technology (Guangzhou) Co., Ltd. ("Shijie Medical" for short) announced the completion of a multi-million A+ round of financing. This follows the successful completion of Shandong Hexin's A round of financing in February 2023, with Shijie Medical once again receiving additional investment from the well-known angel investment firm Wuming Investment.

PULSECARE

Completed nearly 100 million yuan in Series A financing, focusing on medical device innovation in the field of cardiac and pan-vascular treatment.

Pulsecare Medical Technology Co.,Ltd. (referred to as "PULSECARE") has completed a nearly 100-million-yuan Series A round of financing, led by Tasly Capital, with Delian Capital and Tianfeng Capital participating.

Ansukang Medical

Completed a new round of billion-yuan financing, accelerating the implementation of host-free ultrasonic scalpel.

Innovative Device Developer Ansukang Medical (Suzhou) Co., Ltd. ("Ansukang Medical" hereinafter) announced the completion of a new round of financing worth 100 million yuan. This round of financing was jointly invested by Taiping Innovation, Legend Capital, and Shengjing Jincheng.

These financing cases fully demonstrate that the medical industry, driven by both technological innovation and capital power, is ushering in unprecedented development opportunities. In this wave of financing enthusiasm, we have witnessed the responsibility and determination of companies like Guancheng Information Technology (Suzhou) Co., Ltd. and ShineyoMedical, and also felt the confidence of the capital market in the medical industry. With the support of national policies and the push of market demand, China's medical industry is gradually moving to the center of the global stage. We look forward to these enterprises contributing Chinese wisdom and strength to the global healthcare cause in the near future, and jointly writing a new chapter in human health.

▲TextChapter Organization：Innovative Medical Device Network

▲Please indicate the source above when reprinting.

Disclaimer: This article is intended solely for the purpose of information transmission and is for reference only. It does not constitute any advice on investment or treatment; please exercise caution. If the content involves issues related to the work, copyright, or other aspects, to protect the rights and interests of both parties, please contact us, and we will handle it immediately. If this article is reprinted by other platforms, they must take responsibility for the content themselves. The Medical Device Innovation Network is not responsible for any secondary dissemination caused by reprints.

PREVIOUS REVIEW

R&D Investment Showdown: Johnson & Johnson, Medtronic, Mindray... Who Comes Out on Top?

More Than 14,000 Layoffs in Half a Year: Has the Medical Device Sector Emerged from the "Winter"?

Revenue of 14.6 Billion, 341 Units Installed! da Vinci Q2 Wows Wall Street